Nitric oxide and endothelin in oxygen-dependent regulation of vascular tone of human umbilical vein

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 4 54-4, 2003, Pages

  Mildenberger, Eva ^a   Biesel, Beatrix ^a   Siegel, Günter ^b   Versmold, Hans T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Endothelin receptor antagonism; Endothelium; Membrane potential; Nitric oxide synthase inhibition

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; BLOOD VESSEL TONE; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYPERPOLARIZATION; INTRACELLULAR MEMBRANE; MEMBRANE POTENTIAL; MUSCLE ISOMETRIC CONTRACTION; NEWBORN; NORMAL HUMAN; OXYGEN TENSION; PRIORITY JOURNAL; REGULATORY MECHANISM; UMBILICAL VEIN; VASODILATATION;

EID: 0141565342     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00938.2002     Document Type: Article

References (26)

1. Altura BM, Malaviya D, Reich CF, and Orkin LR. Effects of vasoactive agents on isolated human umbilical arteries and veins. Am J Physiol 222: 345-355, 1972.
2. Bjoro K, Haugen G, and Stray-Pedersen S. Altered prostanoid formation in human umbilical vasculature in response to variations in oxygen tension. Prostaglandins 34: 377-384, 1987.
3. Douglas SA and Ohlstein EH. Signal transduction mechanisms mediating the vascular actions of endothelin. J Vasc Res 43: 152-164, 1997.
4. Ehinger B, Gennser G, Owman C, Persson H, and Sjöberg NO. Histochemical and pharmacological studies on amine mechanisms in the umbilical cord, umbilical vein and ductus venosus of the human fetus. Acta Physiol Scand 72: 15-24, 1968.
5. + channels in mediating hypoxic dilation of middle cerebral arteries. Am J Physiol Heart Circ Physiol 267: H580-H586, 1994.
6. Goodwin JW. The impact of the umbilical circulation on the fetus. Am J Obstet Gynecol 100: 461-471, 1968.
7. Hermsmeyer K. Electrophysiology of vascular smooth muscle. In: Microcirculation, edited by Kaley G and Altura BM. Baltimore, MD: University Park Press, 1980, vol. 3, p. 439-459.
8. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, and Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 50: 247-255, 1992.
9. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M, and Yano M. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91: 4892-4896, 1994.
10. Karck U and Breckwoldt M. Functions of the placenta. In: Comprehensive Human Physiology: From Cellular Mechanisms to Integration, edited by Greger R and Windhorst U. Berlin: Springer, 1996, vol. 2, p. 2291-2305.
11. ATP-channels. Br J Pharmacol 120: 728-734, 1997.
12. Lüscher TF, Oemar BS, Boulanger CM, and Hahn AWA. Molecular and cellular biology of endothelin and its receptors-part I. J Hypertens 11: 7-11, 1993.
13. Lüscher TF, Oemar BS, Boulanger CM, and Hahn AWA. Molecular and cellular biology of endothelin and its receptors-part II. J Hypertens 11: 121-126, 1993.
14. McIntyre CA, Williams BC, Lindsay RM, McKnight JA, and Hadoke PWF. Preservation of vascular function in rat mesenteric resistance arteries following cold storage, studied by small vessel myography. Br J Pharmacol 123: 1555-1560, 1988.
15. Mildenberger E, Siegel G, and Versmold HT. Oxygen-dependent regulation of membrane potential and vascular tone of human umbilical vein. Am J Obstet Gynecol 181: 696-700, 1999.
16. Moncada S, Palmer RMJ, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
17. Opgenorth TJ. Endothelin receptor antagonism. Adv Pharmacol 33: 1-65, 1995.
18. Pearce WJ. Mechanisms of hypoxic cerebral vasodilatation. Pharmacol Ther 65: 75-91, 1995.
19. Raguki H, Tabuchi Y, Nakamura M, Nagano M, Higashimori K, Miakmi H, Ogihara T, and Suzuki N. Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun 169: 973-977, 1990.
20. Rees DD, Palmer RMJ, Schulz R, Hodson HF, and Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746-752, 1990.
21. Sexton AJ, Turmaine M, Cai WQ, and Burnstock G. A study of the ultrastructure of developing human umbilical vessels. J Anat 188: 75-85, 1996.
22. + channels mediate dilatation of cerebral arterioles during hypoxia. Cire Res 74: 1005-1008, 1994.
23. Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koosmans HE, Rabelink TJ, and Webb DJ. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor b]ockade blockade. Circulation 97: 752-756, 1998.
24. Woodbury JW and McIntyre DM. Electrical activity of single muscle cells of pregnant uteri studied with intracellular ultra-microelectrodes. Am J Physiol 177: 355-360, 1954.
25. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
26. Yu JC and Davenport AP. Secretion of endothelin-1 and endothelin-2 by human cultured vascular smooth muscle cells. Br J Pharmacol 114: 551-557, 1995.